Expansion of the substrate range of the gentisate 1,2-dioxygenase from Corynebacterium glutamicum for the conversion of monohydroxylated benzoates 
Introduction
The biodegradation of aromatic compounds under aerobic conditions generally results in the formation of dihydroxylated aromatic intermediates. Subsequently, these diols are converted to non-aromatic compounds by oxygenolytic enzymatic reactions. There are three major types of ring-fission dioxygenases known. Catechols (1,2-dihydroxylated aromatic compounds) are oxidised either by intradiol (1,2-, 'ortho-') or extradiol (2,3-, 'meta-') cleaving dioxygenases. Dihydroxylated aromatic compounds which possess a 1,4-(para-) substitution pattern are generally cleaved in direct neigbourhood to one of the hydroxyl groups, by enzymes such as gentisate (2,5-dihydroxybenzoate) 1,2-dioxygenases (GDOs) or hydroquinone (1,4-dihydroxybenzene) 1,2-dioxygenases (Que and Ho, 1996; Vaillancourt et al., 2006; Fetzner, 2012) . There are also some ring-fission dioxygenases known which are able to cleave monohydroxylated aromatic compounds. This ring-fission mechanism was initially demonstrated for 1-hydroxy-2-naphthoate 1,2-dioxygenases (Kiyohara and Nagao, 1977; Iwabuchi and Harayama, 1998; Adachi et al., 1999) . Later, analogous ring-fission reactions were also described for the cleavage of 5-chloro-and 5-nitrosalicylate (Crawford et al., 1979; Spain, 2010, 2011) .
The α-proteobacterium Pseudaminobacter salicylatoxidans encodes a peculiar ring-fission dioxygenase, salicylate dioxygenase (SDO), with the ability to cleave salicylate, various substituted salicylates and also 1-hydroxy-2-naphthoate (1H2NC) (Fig. 1) . The amino acid sequence and the biochemical characterisation of the enzyme suggested that the SDO represents a novel type of GDO which gained the ability to attack monohydroxylated substrates (Hintner et al., 2001 (Hintner et al., , 2004 . In order to study the extraordinary substrate specificity of the SDO several enzyme variants have been generated and biochemically characterised. Furthermore, the crystal structures of the wild-type enzyme and some enzyme variants have been determined in the absence or presence of substrate (Matera et al., 2008; Ferraroni et al., 2012a Ferraroni et al., ,b, 2013 . More recently, the enzyme reaction has also been studied by quantum mechanical/ molecular modelling (QM/MM) studies (Roy and Kästner, 2016) .
In the course of the mutational studies some variants of the SDO were obtained by simple point mutations which lost the ability to oxidatively cleave salicylate but still were able to cleave gentisate. These variants resembled 'conventional' GDOs, which oxidise gentisate but are unable to convert (substituted) salicylate(s) (Ferraroni et al., 2013) . Therefore, the question arose whether the SDO possesses some additional adaptations for the conversion of monohydroxylated substrates or if indeed single amino acid exchanges might be sufficient to convert 'conventional' ringfission dioxygenases into enzymes, which convert monohydroxylated substrates. This would significantly broaden the catalytical potential of ring-fission dioxygenases and would also be important for the understanding of the catalytical mechanism used by this important group of enzymes. In addition, this reaction could allow the synthesis of several products which have never been produced chemically.
Therefore, it was attempted in the present study to extend the substrate spectrum of the 'conventional' GDO from Corynebacterium glutamicum towards the conversion of monohydroxylated substrates. 
Material and methods

Bacterial strains and media
Escherichia coli XL1 Blue (Stratagene, La Jolla, USA) and E. coli BL21(DE3) were used for gene cloning and expression. The recombinant E. coli strains were cultivated in LB-or dYT-media (Sambrook et al., 1989) .
Cloning of the gene coding for the GDO from C. glutamicum
The gene coding for the GDO (GDO Cg ) from C. glutamicum ATCC 13032 (nagI) was obtained from plasmid pJPH200ex (Hintner et al., 2004) . The gene was cut out of plasmid pJPH200ex using NdeI and BamH1 and ligated into the expression vector pET28a (Novagen) by using the same restriction sites. Finally a stop codon (TAG) was introduced 5′ of the gene, giving plasmid pEE004. This plasmid coded for a variant of GDO Cg carrying an aminoterminal His 6 -tag.
Cultivation of organisms and preparation of cell extracts for enzyme purification
The cultures of E. coli BL21(DE3)(pEE004) (or derivatives of pEE004 encoding variants of GDO Cg ) were grown overnight at 30°C in dYT medium plus kanamycin (50 μg/ml). These precultures were used to inoculate 3 l Erlenmeyer flasks containing the same medium (700 ml) to an initial optical density (OD 600 nm ) of about 0.3. These cultures were grown at 37°C and 160 rpm to an OD 600 nm of 0.6-0.8. Then, 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added and the cultures incubated for another 5 h at 30°C and 100 rpm.
The cells were harvested by centrifugation (11 000 g, 4°C, 20 min), suspended in Tris/HCl-buffer (20 mM, pH 8.0) and disrupted by using a French press (Aminco, Silver Springs, MD) at 80 MPa. Cell debris was removed by centrifugation (82 000 g, 4°C, 1 h). The protein content of the cell extracts was determined by the method of Bradford (1976) and bovine serum albumin was used as standard.
Purification of the enzyme
NaCl was added to the cell extracts containing the His-tagged enzyme variants to a final concentration of 300 mM. These solutions (containing about 50 mg of protein) were transferred to columns containing 1 ml of 'NiNTA-matrix-L' (Merck, Darmstadt, Germany) . The proteins were eluted from the column by increasing concentrations of imidazole. The His-tagged GDO Cg and its variants eluted from the column after increasing the imidazole concentration to 200 mM. The fractions with the purified proteins were desalted by using a PD-10 desalting column according to the instructions of the supplier (GE Healthcare) and eluted with 4 ml of Tris/HCl (20 mM, pH 8.0) plus 100 mM NaCl. Finally, the proteins were concentrated using centrifugal concentrators (Vivaspin 500, 10 kDa exclusion volume; Vivascience AG, Hannover, Germany).
Enzyme assays
The conversion of the substrates was determined spectrophotometrically at room temperature (23 ± 1°C) as previously described (Hintner et al., 2001; Eppinger et al., 2016) . One unit of enzyme activity was defined as the amount of enzyme that converted 1 μmol of substrate/min. For the determination of the kinetic constants substrate concentrations of 10, 20, 40, 80, 100, 200 and 500 μM were used and 0.4-12.5 mg of the purified enzyme preparations (according to the enzymes and substrates used). The kinetic constants were calculated by non-linear regression using the Prism4 software (GraphPad, San Diego, CA).
The inhibition of the turn-over of gentisate in the presence of salicylate was analysed by using the same substrate concentrations as described above and five concentrations of the inhibitor salicylate (c = 0-10 mM). The tests were performed twice and the inhibition constant calculated by using the Prism4 software.
HPLC
The products formed enzymatically from 5-fluorosalicylate were separated by HPLC (Agilent 1100) on a reverse phase column by ion-pair chromatography as previously described (Eppinger et al., 2016) . Screening system for the detection of bacterial colonies with the ability to convert salicylate to 2-oxohepta-3,5-dienedioic acid
The recombinant E. coli strains were cultivated overnight at 30°C on LB agar plates containing 50 μg/ml kanamycin and 0.01 mM IPTG. The colonies were blotted to polyvinylidenefluoride membranes (PVDF Western Blotting Membrane, Roche Diagnostics, Mannheim, Germany). The cell material on the membranes was incubated for about 30 min with salicylate (1 mM in 20 mM Naphosphate buffer, pH 8.0, about 5 μl per colony). Then, 2 μl of a 2,4-dinitrophenylhydrazine solution (100 mg in 100 ml 2 M HCl) was added. After 5 min, 5 μl 4 M NaOH was added. Positive colonies showed within a few seconds an intense red coloration.
E. coli BL21(DE3)(pJPH100exN), which codes for a SDOderivative carrying an aminoterminal His 6 -tag (Hintner et al., 2004) , was used as a positive control during the screening experiments.
Determination of the K M -values with salicylate for the mutants identified from the screening of the mutant banks
The cultures of E. coli BL21(DE3) carrying the derivatives of pEE004 obtained by saturation mutagenesis were grown and induced in a 50 ml scale in LB-medium plus kanamycin (50 μg/ml) basically as described above for the preparation of the cells used for enzyme purification. The cells were harvested by centrifugation (3000 g, 4°C, 30 min) and stored frozen at −20°C. The cells were suspended in Na-phosphate-buffer (20 mM, pH 8.0) and disrupted by using a sonicator (Sonoplus HD200, Bandelin, Berlin, Germany). Cell debris was removed by centrifugation in an Eppendorf-type centrifuge (19 000 g, 4°C, 1 h). The resulting supernatants were tested by UV/Vis overlay-spectroscopy for activity with salicylate. The K M -values for salicylate were determined using these cell extracts as described above ('enzyme assays').
Transformation and plasmid isolation
DNA preparation, DNA manipulation and transformation were performed as previously described (Hintner et al., 2004) . Plasmids were isolated by using a 'Nucleospin Plasmid Kit' (Macherey-Nagel, Düren, Germany).
Site-directed and saturation mutagenesis
The site directed mutations were generated by using the 'QuikChange site directed mutagenesis kit' according to the instructions given by the supplier (Agilent, Santa Barbara, CA). The sequences of the genes coding for salicylate converting variants of GDO Cg were determined by DNA sequencing (GATC Biotech, Konstanz, Germany).
For saturation mutagenesis in individual codons the following primers (5′ → 3′) were used: Sat91-fw:GGCGAACGCCGTnnkATTGGCCTGGCAAACCCAGG; Sat91-rv-GCCAGGCCAATnnmACGGCGTTCGCCACCGC; Sat112:fw:CCTACCCTGTGGGCAnnkATTCAGTACCTCGCTCC GGGTG; Sat112-rv:CGAGGTACTGAATnnmTGCCCACAGGGTAGGGGA GATGTAGG; Sat110-fw:CCCCTACCCTGnnkGCAGCAATTCAGTACCTCGCT CCGG; Sat110-rv:GGTACTGAATTGCTGCnnmCAGGGTAGGGGAGATG TAGG. The experiments were performed three times (technical replicas). The results were analysed by non-linear regression and the standard errors calculated using the program Prism 4 (GraphPad Software).
Sequence comparisons, dendrogram generation, calculation of kinetic data and graphical representation of structures
The GDOs used for the sequence comparisons and their NCBI numbers have been described previously (Eppinger et al., 2015) . The dendrograms were generated by using the ClustalW2-phylogeny online-service (http://www.ebi.ac.uk/Tools/phylogeny/clustalw2_phyl ogeny/) and the Unweighted Pair Group Method with Arithmetic Mean (UPGMA) algorithm (Larkin et al., 2007) . UCSF Chimera was used for the presentation of enzyme structures (Pettersen et al., 2004) .
Results
Sequence comparisons between the SDO and various gentisate-1,2-dioxygenases and 1-hydroxy-2-naphthoate 1,2-dioxygenases Sequence comparisons between the SDO from P. salicylatoxidans and the sequences of various GDOs and 1-hydroxy-2-naphthoate 1,2-dioxygenases (HNDOs) from various sources demonstrated that the SDO was indeed positioned among the bacterial GDOs. Particularly, the SDO seems to belong to a subgroup of GDOs which almost exclusively encompasses GDOs from Gram-positive bacteria. Furthermore, it became evident that the HNDOs and the GDOs from haloarchaea are separated from the bacterial GDOs (Fig. 2) .
Substrate specificity of the GDO from C. glutamicum
The dendrogram demonstrated that the GDO from C. glutamicum (GDO Cg ) and the SDO from P. salicylatoxidans were closely related. The protein sequences showed 60.3% identity. The gene coding for the GDO Cg belongs to an operon which enables C. glutamicum to grow on gentisate as sole source of carbon and energy (Shen et al., 2005) . The gene coding for GDO Cg had been previously cloned and it had been demonstrated that GDO Cg converted gentisate but not salicylate (Hintner et al., 2004) . In order to further characterise GDO Cg the encoding gene was cloned into a pET28a expression vector and heterologously expressed as a His-tagged protein in E. coli BL21(DE3). The purified GDO Cg was incubated with gentisate, salicylate, 1H2NC and various substituted salicylates (3-and 4-hydroxysalicylate; 3-, 4-and 5-chlorosalicylate; 5-fluorosalicylate; 3-, 4-and 5-aminosalicylate; 3-, 4-and 5-methylsalicylate; 3-, 4-and 5-bromosalicylate; 5-iodo-, 5-sulfo-, 5-nitro-and 5-carboxysalicylate). The reactions were analysed by recording overlay-spectra using a UV/Vis-spectrophotometer. This demonstrated that GDO Cg showed a pronounced activity only with gentisate. In addition, small changes in the UV/Vis spectra were also observed with 5-aminoand 5-fluorosalicylate (Fig. 4) .
It was tested if GDO Cg was at least able to bind salicylate. Therefore, different concentrations of gentisate were converted in the presence of increasing amounts of salicylate and the reaction rates determined spectrophotometrically. This suggested a competitive inhibition of gentisate oxidation by salicylate with an inhibition constant (K i ) of 2.7 ± 0.2 mM.
The kinetic constants V max , K m , k cat and k cat /K m for the conversion of gentisate, 1H2NC, salicylate, 5-amino and 5-fluorosalicylate were determined for GDO Cg and compared to the results previously obtained for the SDO (Table I) . GDO Cg converted gentisate slightly more effective than the SDO, but showed even with the two additional substrates which were oxidised (5-amino-and 5-fluorosalicylate) significantly lower kinetic constants (k cat /K m -values). This demonstrated that GDO Cg was highly specialised for the conversion of gentisate.
Identification of an amino acid residue which could prevent the oxidation of monohydroxylated substrates by GDO Cg During the previously performed mutational studies with the SDO the enzyme variant SDO Gly106Ala was generated, which still effectively converted gentisate, but did not oxidise salicylate anymore (Ferraroni et al., 2013) . Thus, this phenotype clearly resembled that observed with GDO Cg and other 'conventional' GDOs. The substrate specificities of SDO Gly106Ala and GDO Cg were also rather similar for the conversion of 5-amino-and 5-fluorosalicylate (Table I) . A comparison of the amino acid sequences of the SDO and GDO Cg in combination with structural modelling demonstrated that GDO Cg possessed an alanine residue at the relevant position (Fig. 3) . This suggested that the presence of this alanine residue (Ala112) in GDO Cg could be responsible for the unability of GDO Cg to convert salicylate.
The enzyme variant GDO Cg_Ala112Gly was generated by site-specific mutagenesis, purified and analysed by overlay spectroscopy for the conversion of various substituted salicylates. This demonstrated that the variant GDO Cg_Ala112Gly indeed converted salicylate, 3-and 4-hydroxysalicylate; 3-, 4-and 5-chlorosalicylate; 4-aminosalicylate; 3-, 4-and 5-methylsalicylate; 3-and 4-bromosalicylate; 5-iodosalicylate; and 1-hydroxy-2-naphthoate which were not converted by the wild-type enzyme GDO Cg (Fig. 4) . The spectrum of substituted salicylates converted by GDO Cg_Ala112Gly clearly resembled the substrate spectrum previously determined for the SDO (Hintner et al., 2004) .
Subsequently, the basic kinetic constants with gentisate, 1H2NC, salicylate, 5-amino-and 5-fluorosalicylate were determined for the GDO Cg_Ala112Gly variant and compared with the wild-type GDO Cg and the SDO (Table I) . Recently, it was demonstrated that 5-fluorosalicylate was converted by the SDO to two non-fluorinated products which were identified as stereoisomers of the 'dienelactone' 2-oxo-3-(5-oxofuran-2-ylidine)propanoic acid (Fig. 1) . Furthermore, it was found that 5-fluorosalicylate was converted to the same products by the 5-nitrosalicylate 1,2-dioxygenase from Bradyrhizobium sp. JS329, but that both enzymes Fig. 4 Conversion of various substituted salicylates by the purified His-tagged gentisate 1,2-dioxygenase from C. glutamicum ATCC 13032 (GDO Cg ) and its variant GDO Cg_Ala112Gly . The reaction mixtures contained in 1 ml 20 mM Na-phosphate buffer (pH 8.0) and 0.25 mM of the respective substrates and 0.5-125 μg protein. The spectra were recorded every minute against a reference cuvette which contained the same amount of protein in Na-phosphate buffer but without the respective substrates. The following amounts of protein were added for the tests with GDO Cg and GDO Cg_Ala112Gly , respectively: gentisate (0.6 or 0.5 μg), 1H2NC (1.8 or 1.5 μg), 5-fluoro-and 5-aminosalicylate (9 or 7.5 μg, each), 5-methylsalicylate (12.1 or 10.4 μg), salicylate (15.1 or 13 μg), 4-chloro-and 4-bromosalicylate (48.2 or 41.8 μg, each), 3-methyl-, 3-hydroxy-and 4-hydroxysalicylate (72.3 or 62.7 μg, each), all other substrates (120 or 105 μg, each).
formed the two 'dienelactones' in different proportions (Eppinger et al., 2016) . The results presented above showed that GDO Cg had some 'basal' activity with 5-fluorosalicylate and that this activity significantly increased for the GDO Cg_Ala112Gly variant. Therefore, it was tested if the Ala112Gly mutation possessed any influence on the stereochemistry of the reaction. Thus, 5-fluorosalicylate was converted by GDO Cg and GDO Cg_Ala112Gly and the reactions analysed by HPLC. This demonstrated that GDO Cg formed the two isomeric 'dienelactones' in a ratio of about 1:3.2, compared to a value of about 1.3:1 observed for the SDO (Eppinger et al., 2016) . Interestingly, the GDO Cg_Ala112Gly variant formed the two isomers in a ratio of 1:1.3 and thus resembled the SDO also in this respect.
Development of a colorimetric assay system for the detection of the 1,2-cleavage of salicylate
The results obtained with the GDO Cg_Ala112Gly variant clearly demonstrated that a 'conventional' GDO could be converted to an enzyme with a salicylate oxidising activity by a simple point mutation. This suggested that it might be possible to identify also other mutations leading to a similar or even more pronounced activity with salicylate. Therefore, it was necessary to be endowed with a colorimetric assay in order to screen a larger number of enzyme variants for the desired phenotype. The ring-fission product of salicylate (2-oxohepta-3,5-dienedioic acid) (Fig. 1) has an absorption maximum (λ max ) at 283 nm and is therefore colourless. Thus, several established tests for the detection of α-keto acids or diacids were tested if they allowed a discrimination between salicylate and the ring-fission product (most of the them taken from Krebs et al., 1969 , or a manual from Merck, 1970) . Thus, reactions with KMnO 4 / NaCO 3 , or an acid solution of FeCl 3 (also with HONH 2 ·HCl), or CuSO 4 , or 2,4-dinitrophenylhydrazine plus HCl, or solutions of bromocresol purple or fuchsine were tested. These tests resulted either in no coloration of salicylate and the ring-fission product or in the formation of the same colour from both compounds. Finally, it was found that a reaction with 2,4-dinitrophenylhydrazine, originally described for the detection of α-keto acids (by the formation of the corresponding hydrazones) in blood and urine (Friedemann and Haugen, 1943) , could be used. Thus, a colony screening was established which allowed to detect bacterial colonies with the ability to oxidatively cleave salicylate after blotting the colonies to PVDF membranes (see materials and methods section). The assay system did not require any explicit cell lysis step, presumably because of the subsequent usage of strongly acidic and alkaline conditions. Various assays with different concentrations of salicylate suggested a detection limit of about 0.1 mM for the oxidation product of salicylate (Fig. 5) .
Saturation mutagenesis of GDO Cg at positions 91, 110 and 112
The feasibility of the newly developed assay for the detection of salicylate converting enzyme variants was tested by performing a saturation mutagenesis of the gene encoding GDO Cg at position 112. Thus, from 186 clones 12 were identified in the initial screening which potentially converted salicylate (a representative plate is shown in Fig. 6 ). Then, cell extracts were prepared from these 12 clones and kinetic data determined for the conversion of salicylate. The variants could be grouped into three clusters according to the K M -values for the conversion of salicylate (13 ± 3 μM, 105 ± 7 μM and 1000 ± 100 μM, respectively). Subsequently, the encoding genes were sequenced and it was found that the three identified groups correlated with the amino acid exchanges Ala112Ser (low K Mvalues), Ala112Gly (medium range K M -values) and Ala112Asp (high K M -values). The recombinant E. coli strains were cultivated overnight at 30°C on LB agar plates containing 50 μg/ml kanamycin and 0.01 mM IPTG. The colonies were transferred to PVDF membranes. Subsequently, different concentrations of salicylate (0.1-1 mM) were individually pipetted on the different blotted colonies. After 30 min, 2,4-dinitrophenylhydrazine and NaOH were added as described in the materials and methods section. SDO E. coli BL21(DE3) (pJPH100exN); pET28a E. coli BL21(DE3)(pET28a) ('vector control'), Na-PP no salicylate added (only Na-phosphate buffer). In a further set of experiments, it was tested if also modifications in other amino acid residues could enable GDO Cg to convert salicylate. Therefore, analogous saturation mutagenesis experiments were performed at positions Ala91 and Trp110. These residues were chosen because they were homologous to residues Ala85 and Trp104 in the SDO, which had been previously identified to be important for the ability of the SDO to convert salicylate and 1H2NC. Furthermore, both residues are located in the SDO structure close to Gly106 (homologous to Ala112 in GDO Cg ) (Ferraroni et al., 2012b) . Unfortunately, no salicylate converting clones could be detected in these screens.
Discussion
The oxidative cleavage of monohydroxylated aromatic systems has been described for different (substituted) salicylates and 1H2NC (Kiyohara and Nagao, 1977; Crawford et al., 1979; Iwabuchi and Harayama, 1998; Adachi et al., 1999; Spain, 2010, 2011) . It currently appears that the conversion of this type of compounds relies on a specific type of ring-fission dioxygenases which previously have often been designated as 'extradiol dioxygenases of type III'. The sequence information obtained more recently for this group of enzymes has demonstrated that these enzymes belong to the cupinsuperfamily and are therefore evolutionary not related to the extradiol dioxygenases, such as the archaetypical catechol-2,3-dioxygenases (Dunwell et al., 2004; Fetzner, 2012) . Although the ring-fission dioxygenases which belong to the cupin superfamily are potentially able to cleave monohydroxylated compounds such as 1H2NC or (substituted) salicylates, the data available for GDOs suggest that some further molecular adaptations are required in order to allow the ring-fission of salicylates. Thus, it had been repeatedly reported in the literature for GDOs from different sources [e.g. from Pseudomonas ovalis S-5, Comamonas (Pseudomonas) testosteroni, Delftia (Pseudomonas) acidovorans] that these enzymes oxidise gentisate, but not salicylate or substituted salicylates (with the exception of 5-aminosalicylate) (Sugiyama et al., 1960; Harpel and Lipscomb, 1990a,b) . This has been confirmed in the course of the present work for the GDO from C. glutamicum ATCC 13032.
The comparison of the kinetic constants previously obtained for the SDO wild-type and in the present study with the GDO Cg_Ala112Gly variant showed that both enzymes converted a similar range of monohydroxylated aromatic compounds. Furthermore, also the relative catalytic efficiencies (k cat /K M -values) of both enzymes with different substrates were rather similar and it was evident that the binding constants for the substrate salicylate were in the μM range (Table I) . Not only the SDO and the GDO Cg_Ala112Gly variant resembled each other, but also the SDO Gly106Ala variant and GDO Cg . In this respect, it was especially relevant that both enzymes did not convert salicylate, but that salicylate could act as competitive inhibitor and was bound in the mM range.
The similarities between SDO and GDO Cg_Ala112Gly respectively SDO Gly106Ala and GDO Cg suggested that a possible explanation for the unability of GDO Cg and other 'conventional' GDOs to oxidise salicylate could be deduced from previously performed structural comparisons of the SDO wild type enzyme and SDO Gly106Ala . These structural comparisons demonstrated that in the SDO Gly106Ala variant salicylate was not bound to the catalytically active ferrous iron productively by the 1-carboxy-and 2-hydroxy-groups of the substrate but only via the carboxylate group (Ferraroni et al., 2013) . Thus it seems very probable that also in GDO Cg and other GDOs from Gram-positive bacteria the conversion of salicylate is hindered by an unproductive binding of the substrate. Surprisingly, sequence alignments demonstrated that most GDOs from Gram-negative bacteria harbour at the position homologous to Gly106 in the SDO and Ala112 in GDO Cg a glycine residue and only a minority an alanine residue such as GDO Cg (Fig.7) . The correlation of the sequence comparisons with the dendrogram shown in Fig. 1 and the structures determined previously for the SDO suggested that most Gram-positive bacteria possess in this part of the substrate binding cavity an amino acid triad consisting of (SDO/GDO Cg -numbering) Ala (85/91), Trp (104/110), Ala (106/112). In contrast, most Gram-negative bacteria show at the relevant positions the sequence motif Val-Tyr-Gly. Therefore, the SDO (with the motif Ala-Trp-Gly) represents somehow an intermediate between the typical motives found in Gram-positive and Gram-negative bacteria.
It has been previously shown for the GDO from Delftia (Pseudomonas) acidovorans that salicylate is not converted but acts in a millimolar range as competitive inhibitor (Harpel and Lipscomb, 1990b) . The amino acid sequence of this enzyme shows the typical Val-Tyr-Gly-motif found in the GDOs from most Gram-negative bacteria as described above (E.E. unpublished results). This illustrates that (at least in the case of the typical GDOs from Gram-negative bacteria) a glycine residue at the relevant position is not sufficient in order to enable a GDO to convert (substituted) salicylate(s). Furthermore, the observed competitive inhibition suggests that salicylate is also bound to this group of GDOs in a 'wrong orientation' as determined for the SDO Gly106Ala variant. Thus, it appears that in the GDOs from Gram-negative bacteria different factors prevent the turn-over of salicylate. We believe that the newly developed colorimetric screening system will allow us to tackle these open questions.
